IL-13 Inhibits TNF Production but Potentiates That of IL-6 in Vivo and Ex Vivo in Mice

Elena Di Santo, Cristina Meazza, Marina Sironi, Paolo Fruscella, Alberto Mantovani, Jean D. Sipe, Pietro Ghezzi

Research output: Contribution to journalArticlepeer-review

Abstract

IL-13 was reported to inhibit the synthesis of various cytokines in vitro, including that of TNF. It has divergent effects on IL-6 production, which is increased in endothelial cells and decreased in monocytes. We studied the effect of IL-13 administration on TNF and IL-6 production in vivo in mice. IL-13 (1 μg/mouse, i.v., 10 min to 6 h before LPS) decreased LPS (100 ng/mouse, i.v.)-induced serum TNF levels by 50%, while it increased the levels of IL-6 by fourfold. IL-13 potentiated IL-1β (100 ng/mouse, i.v.)-induced serum IL-6 levels as well as IL-1- or LPS-induced serum amyloid A. When blood from IL-13-treated mice was stimulated with LPS in vitro, TNF production was decreased fivefold, and that of IL-6 was slightly decreased. We also cultured in vitro the aorta obtained from IL-13-pretreated mice and found that they produce more IL-6 (up to sevenfold) than aorta from control mice. Little or no TNF could be detected in these samples. Thus, IL-13 in vivo inhibits serum TNF but up-regulates serum IL-6. The differential regulation of IL-6 and TNF together with the results of ex vivo experiments could be explained by hy- pothesizing that the cellular origins of the two cytokines are different.

Original languageEnglish
Pages (from-to)379-382
Number of pages4
JournalJournal of Immunology
Volume159
Issue number1
Publication statusPublished - 1997

ASJC Scopus subject areas

  • Immunology

Fingerprint Dive into the research topics of 'IL-13 Inhibits TNF Production but Potentiates That of IL-6 in Vivo and Ex Vivo in Mice'. Together they form a unique fingerprint.

Cite this